Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Management of Latent Autoimmune Diabetes of Adults (LADA) or Type 1 Diabetes in Adults

Diagnosis and Clinical Presentation

  • The combination of thin body habitus, history of gestational diabetes, and failure of oral agents strongly suggests latent autoimmune diabetes of adults (LADA) or type 1 diabetes rather than type 2 diabetes, and should be transitioned to insulin therapy immediately while checking C-peptide and GAD antibodies to confirm the diagnosis, as recommended by the American Diabetes Association 1, 2
  • Women with a history of gestational diabetes who later develop diabetes in their 60s while remaining thin likely had underlying autoimmune beta-cell destruction that was unmasked during pregnancy, according to the American College of Obstetricians and Gynecologists 1

Immediate Treatment

  • Insulin is the preferred and necessary treatment for this patient, as stated by the American Diabetes Association 3, 2, 4, 1
  • Start basal insulin (such as insulin detemir or glargine) at 0.1-0.2 units/kg/day, as recommended by the Endocrine Society 3

Diagnostic Tests

  • Order C-peptide level (fasting or random) - will be low/undetectable in insulin deficiency, as indicated by the American Association of Clinical Endocrinologists 3
  • Order GAD antibodies (glutamic acid decarboxylase) - positive in LADA/type 1 diabetes, according to the American Diabetes Association 1
  • Order IA-2 antibodies - additional autoimmune marker, as recommended by the European Association for the Study of Diabetes 3
  • Order Hemoglobin A1C - assess overall glycemic control, as stated by the International Diabetes Federation 1

Glycemic Targets

  • Aim for fasting blood glucose: 80-130 mg/dL, as recommended by the American Diabetes Association 2
  • Aim for postprandial (2 hours after meals) blood glucose: <180 mg/dL, according to the European Association for the Study of Diabetes 2
  • Aim for A1C goal: <7% (or <6.5% if achievable without hypoglycemia), as stated by the American College of Endocrinology 1

Long-term Management

  • Multiple daily injections (basal-bolus regimen) or insulin pump therapy may be needed, as recommended by the International Diabetes Federation 4
  • Carbohydrate counting education, as stated by the Academy of Nutrition and Dietetics 3
  • Continuous glucose monitoring may be beneficial for optimizing control, according to the American Association of Clinical Endocrinologists 3
  • Endocrinology referral for specialized diabetes management, as recommended by the Endocrine Society 2